Impact Factor
4.89
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
39.73
18,331 total citations
h5-index
159
h5 depth signal
Cited share
94.5%
466 of 493
Total citations
18,331
Citation footprint
Metric signal
38.22
External metric anchor
Self-citation
1.3%
240 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
1,581
United States
465
Germany
118
Italy
94
United Kingdom
73
Citing Fields of Research
Noncoding RNA
863
Cancer & Development
659
Immunology
514
Oncology
473
Cancer, Autophagy & Apoptosis
292
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,036
Articles tracked across the journal lifetime
Indexed publication set
493
466 cited publications
Last 12 months
370
30.8 publications/month
Open access share
100.0%
370 OA publications in the last year
Leading citing country
China
1,581 citing publications
Leading citing field
Noncoding RNA
863 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v1n1,2002-
v1n1,2002-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Cancer & Development
Noncoding RNA
Oncology
Cancer, Autophagy & Apoptosis
Issuing & Sponsoring Bodies
Contributor
BioMed Central Ltd
Broad Categories
Neoplasms
Noncoding RNA
Immunology
Cancer, Autophagy & Apoptosis
Cancer & Development
Lung Cancer
MeSH Descriptors
Molecular Biology
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1186/s12943-026-02813-4
Open DOI
Liquid-liquid phase separation in cancer radiotherapy and immunotherapy: emerging roles and translational opportunities
Liquid-liquid phase separation (LLPS) is a physicochemical process through which biomolecules assemble into membraneless condensates via weak, multivalent interactions. LLPS has emerged as a central biological principle that helps explai...
03
DOI 10.1186/s12943-026-02812-5
Open DOI
Tumor-associated CALD1 splicing variant driven by hnRNPA1 promotes colorectal cancer metastasis
04
DOI 10.1186/s12943-026-02790-8
Open DOI
The PD-1/PD-L1 axis in cancer: from immune evasion mechanisms to next-generation therapeutics
05
DOI 10.1186/s12943-026-02817-0
Open DOI
Antibody-drug conjugates: mechanism, progress and future directions of cancer targeted therapy
06
07
DOI 10.1186/s12943-026-02808-1
Open DOI
It takes two to tango: the intersection of deubiquitinases and m6A modification in cancer
The dynamic and reversible N6-methyladenosine (m6A) RNA modification has emerged as a pivotal layer of epitranscriptomic regulation in cancer, governing RN
08
DOI 10.1186/s12943-026-02810-7
Open DOI
Oncogenic KRAS drives immune evasion through adenosine metabolic reprogramming mediated by NT5E and ADA
09
DOI 10.1186/s12943-026-02809-0
Open DOI
Targeting TEAD in cancers: paralog-specific biology, resistance and therapeutic opportunities
The TEA domain transcription factors TEAD1 to TEAD4 integrate Hippo signaling with transcriptional programs that govern tissue homeostasis and cancer progression. Their activity is shaped by cofactor engagement, palmitoylation, chromatin...
10
Bibliographical & Catalog Notes
Title from PDF caption (viewed Apr. 29, 2004).
Latest issue consulted: 3:13 (27 Apr. 2004)) (viewed Apr. 29, 2004).
Articles are numbered consecutively within each vol., one vol. each year, and added individually to the site.
Mode of access: World Wide Web.